Penn Medicine Provider
Neurosurgery
Steven Brem, MD
4.7
(30)
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurosurgery

About me

  • Course Director, Annual Penn Brain Tumor CME
  • Site Director, Perelman School of Medicine Surgery Rotation - Neurosurgery at HUP
  • Director, Neurosurgery Medical Student Education
  • Professor CE of Neurosurgery

Education and training

  • Medical School: Harvard University
  • Residency: Massachusetts General Hospital
  • Fellowship: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: University of California, Los Angeles

What my patients think about me

Average Rating
4.7

30 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2020
5.0
5.0
We appreciate the top notch professionals in this office. Every level of care was excellent
September 2020
5.0
5.0
Dr Brem was awesome.
March 2020
3.0
3.0
constantly interrupted from explaining my condition to answer cellphone
January 2020
5.0
5.0
again the staff are very friendly and helpful

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Brem is a Penn Medicine physician.

Qualifications and experience

My research

Brem S, Hoch MJ. Commentary: Resting State Functional Networks in Gliomas: Validation With Direct Electrical Stimulation Using a New Tool for Planning Brain Resections , Neurosurgery: 2024


Guo J, Fathi Kazerooni A, Toorens E, Akbari H, Yu F, Sako C, Mamourian E, Shinohara RT, Koumenis C, Bagley SJ, Morrissette JJD, Binder ZA, Brem S, Mohan S, Lustig RA, O'Rourke DM, Ganguly T, Bakas S, Nasrallah MP, Davatzikos C. Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach , Sci Rep, 14: 2024,4922


Bagley SJ, Binder ZA, Lamrani L, Marinari E, Desai AS, Nasrallah MP, Maloney E, Brem S, Lustig RA, Kurtz G, Alonso-Basanta M, Bonté PE, Goudot C, Richer W, Piaggio E, Kothari S, Guyonnet L, Guerin CL, Waterfall JJ, Mohan S, Hwang WT, Tang OY, Logun M, Bhattacharyya M, Markowitz K, Delman D, Marshall A, Wherry EJ, Amigorena S, Beatty GL, Brogdon JL, Hexner E, Migliorini D, Alanio C, O'Rourke DM. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial , Nat Cancer, 5: 2024,517-531


Lu Y, Lee J, Li J, Allu SR, Wang J, Kim H, Bullaughey KL, Fisher SA, Nordgren CE, Rosario JG, Anderson SA, Ulyanova AV, Brem S, Chen HI, Wolf JA, Grady MS, Vinogradov SA, Kim J, Eberwine J. CHEX-seq detects single-cell genomic single-stranded DNA with catalytical potential , Nat Commun, 14: 2023,7346


de Godoy LL, Chawla S, Brem S, Mohan S. Taming Glioblastoma in "Real Time": Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology , Clin Cancer Res, 29: 2023,2588-2592


Richardson TE, Yokoda RT, Rashidipour O, Vij M, Snuderl M, Brem S, Hatanpaa KJ, McBrayer SK, Abdullah KG, Umphlett M, Walker JM, Tsankova NM. Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma , Neurooncol Adv, 5: 2023,vdad085


Sampson JH, Singh Achrol A, Aghi MK, Bankiewicz K, Bexon M, Brem S, Brenner A, Chandhasin C, Chowdhary S, Coello M, Ellingson BM, Floyd JR, Han S, Kesari S, Mardor Y, Merchant F, Merchant N, Randazzo D, Vogelbaum M, Vrionis F, Wembacher-Schroeder E, Zabek M, Butowski N. Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial , Neuro Oncol, 25: 2023,1085-1097


Nabavizadeh A, Bagley SJ, Doot RK, Ware JB, Young AJ, Ghodasara S, Zhao C, Anderson H, Schubert E, Carpenter EL, Till J, Henderson F Jr, Pantel AR, Chen HI, Lee JYK, Amankulor NM, O'Rourke DM, Desai A, Nasrallah MP, Brem S. Distinguishing Progression from Pseudoprogression in Glioblastoma Using (18)F-Fluciclovine PET , J Nucl Med, 64(6): 2023


de Godoy LL, Chawla S, Brem S, Wang S, O'Rourke DM, Nasrallah MP, Desai A, Loevner LA, Liau LM, Mohan S. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model , J Neurooncol, 163(1): 2023


Golkar E, Parker D, Brem S, Almairac F, Verma R. CrOssing fiber Modeling in the Peritumoral Area using dMRI (COMPARI) , bioRxiv: 2023


View all publications